Boudewijn Van de Maele

Statistics

Publications

Citations

305

H-Index

Active since

2008

Affiliations

AZ Sint-Jan(Current)

Novartis (United Kingdom)

Boudewijn Van de Maele is an author at AZ Sint-Jan specializing in pharmacotherapy, chronic obstructive pulmonary disease, and bronchodilator efficacy.

Publications per year

2008–2010

Publications

“Real-life” effectiveness of omalizumab in patients with severe persistent allergic asthma: The PERSIST study

Guy Brusselle, Alain Michils, Renaud Louis et al. · Respiratory Medicine · 2009 · 198 citations · Full text

Life Sciences, Immunology, Pharmacotherapy +16

Cardiovascular Safety of QVA149, a Combination of Indacaterol and NVA237, in COPD Patients

Boudewijn Van de Maele, Leonardo M. Fabbri, Rachael Horton et al. · COPD Journal of Chronic Obstructive Pulmonary Disease · 2010 · 61 citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +17

24-hour bronchodilator efficacy of single doses of indacaterol in subjects with COPD: comparison with placebo and formoterol

Olivier Bauwens, Vincent Ninane, Boudewijn Van de Maele et al. · Current Medical Research and Opinion · 2008 · 46 citations

Medicine, Pharmacology, Pharmacotherapy +16

1–3 of 3